Načítá se...
Treatment of natalizumab‐associated PML with filgrastim
OBJECTIVE: There is no consensus on the treatment of progressive multifocal leukoencephalopathy (PML) occurring in multiple sclerosis (MS) patients treated with natalizumab (Nz). We report novel immune activating treatment with filgrastim of Nz‐associated PML in MS patients treated at Rush Universit...
Uloženo v:
| Vydáno v: | Ann Clin Transl Neurol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6529830/ https://ncbi.nlm.nih.gov/pubmed/31139690 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.776 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|